Abhay_Chauhan_CV_12-31-2021.5755474944

Nahata College of Pharmacy, Mandsaur, India ADMINISTRATIVE APPOINTMENTS: 06/11 - 12/16 Director of Pharmaceutical Nanotechnology, School of Pharmacy, Concordia University Wisconsin, Meq

Date of Document: December 31, 2021

CURRICULUM VITAE

Abhay Chauhan PhD

Associate Professor

Department of School of Pharmacy Administration

Division of Administration

OFFICE ADDRESS:

Health Research Center

8701 Watertown Plank Rd

Milwaukee, WI 53226

EDUCATION:

07/0 - 09/4 Ph.D Indian Institute of Chemical Technology, Hyderabad, India/HS Gour University

08/92 - 06/96 Bachelors in Pharmacy (B.Pharm), Dr Hari Singh Gour University, Sagar, India (FPGEC certificate by N

01/97 - 12/98 Masters in Pharmacy (M Pharm) Dr Hari Singh Gour University, Sagar, India

FACULTY APPOINTMENTS:

06/11 - 12/16 Director of Pharmaceutical Nanotechnology, Assistant Professor, School of Pharmacy Master of Pharmaceutical Product Development, Concordia University Wisconsin, Mequon, WI

01/17 - 06/19 Assistant Professor, School of Pharmacy, Medical College of Wisconsin

07/19 - Present Associate Professor, School of Pharmacy, Medical College of Wisconsin

09/96 - 12/96 Lecturer in Pharmaceutical Sciences, Awadhesh Pratap Singh University, Rewa, India 02/99 - 06/99 Lecturer in Pharmaceutics, B.R Nahata College of Pharmacy, Mandsaur, India

ADMINISTRATIVE APPOINTMENTS:

06/11 - 12/16 Director of Pharmaceutical Nanotechnology, School of Pharmacy, Concordia University Wisconsin, Mequon, WI

RESEARCH ADMINISTRATIVE APPOINTMENTS:

10/4 - 05/10 Head, Formulation Development, Dendritic Nanotechnologies, Inc, Mt Pleasant, MI

06/10 - 12/14 Scientific Director/Senior Consultant, Nanosynthons LLC, Mount Pleasant, MI

01/15 - 03/18 Founder and CTO, Vivoform Inc., Milwaukee, WI

06/18 - Present Founder, CEO, Amruth Inc

07/99 - 06/0 Scientist, Drug delivery, Transgene Biotech, Hyderabad, India

SPECIALTY BOARDS AND CERTIFICATION:

Intellectual property management World Intellectual Property Organization, 2005 None

AWARDS AND HONORS:

1991 - Present National Fellowship holder for securing high rank among 12th grade students in the country (<5 % students would receive this award) All India Council for Technical Education

1996 - Present Junior Research Fellowship (Graduate Aptitude Test in Engineering- GATE-96)

Qualifying in GATE is a mandatory requirement for seeking admission and/or financial assistance for premier doctoral and ma

2000 - Present Senior Research Fellowship by Council of Scientific and Industrial research, India (equivalent to NIH) Based on National Aptitude Screening Test for financial assistance to pursue PhD

2005 - Present Certified course on intellectual property management from world intellectual property

organization (WIPO), Geneva.

2007 - Present Team member to prepare nanomaterial classification roadmap 'Periodic Patterns,

Relationships, and Categories of Well-Defined Nanoscale Building Blocks' National Science Foundation Workshop

2014 - Present Article containing my research area and picture in Wisconsin Biz (2014) and other news articles

2015 - Present Contributed to the nanotechnology white paper article by Association of Public Health Laboratories (APHL)

2019 - Present Published a book on Pharmaceutical Applications of Dendrimers, Elsevier

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:

2012 - Present Pharmacy Society of Wisconsin

2013 - Present New York Academy of Science

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:

Journal Review

• European Journal of Pharmaceutics and Bio- pharmaceutics

• ACS Omega

• Journal of Biomaterials Science

• European Journal of Medicinal Chemistry

• Journal of Drug Targeting

• Journal of Colloid Science and Biotechnology

• PLOS one, Bioorganic & Medicinal Chemistry

• Drug Development of Industrial Pharmacy

• Journal of Nanoparticle research

• Colloids and Surfaces B: Biointerface

• Journal of Nanoparticle research

• Drug Delivery Journal

• Nanoscale advances, RSC

European Journal of Pharmaceutical Sciences

• Appreciation letter from the Editor of the Nanomedicine journal for my role as a reviewer (2014)

• Received 'Certificate of Reviewing' In recognition of the reviews done for from The Editors of

Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, Amsterdam, The Netherlands 2018)

• Evidence-Based Complementary and Alternative Medicine

• Nanomedicine: Nanotechnology, Biology, and Medicine

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:

• PRTS (French equivalent of NIH) 2013

• National Science Foundation, Poland 2014

• NIH Reviewer, Special Emphasis Panel/Scientific Review Group 2014/05 ZCA1 SRLB-U (C1) B

• NIH Reviewer, ETTN M50 SBIR; June 2014 cycle

• NIH Reviewer, ETTN M50 SBIR; October 2014 cycle

• NIH Reviewer, ETTN M50 SBIR; February 2015 cycle

• NIH Reviewer, SBIR-ETTN- C55; November 2019 cycle

• NIH Reviewer, ETTN-D50 SBIR; June 2016 cycle

• NIH Reviewer, ETTN-D50 SBIR; October 2016 cycle

• NIH Reviewer, ETTN-D-50 SBIR; March 2018 cycle

• NIH Reviewer, ETTN-D-50 SBIR; June 2018 cycle

• NIH Reviewer, ETTN-D-50 SBIR; November 2018 cycle

• NIH Reviewer, ETTN M50 SBIR; October 2015 cycle

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:

Active

Peer Review

Title: Dendrimer-resveratrol formulation for effective anti-inflammatory and antioxidant activities via dermal application Source: 2 Therapeutic Accelerated Program

Role: Principal Investigator

Dates: 2017 - Present

Direct Funds: $50,000

Title: Dendrimer-resveratrol formulation for effective anti-inflammatory and antioxidant activities via dermal application Source: Therapeutic Accelerated Program

Role: Principal Investigator

Dates: 2018 - Present

Direct Funds: $50,000

Non-Peer

Review

Title: Develop dendrimer-based nanomedicine

Source: In Recognition of Outstanding Scientific Activities and Works of Excellence in Dendrimer Based Nanomedicine by Dow Chemical Foundation and Dr Donald A

Tomalia Family Trust Role: Principal Investigator

Dates: 2018 - Present

Direct Funds: $5,000

Pending

Peer Review

Title: Drugs for targeting vascular malformations

Role: Co-Investigator

Title: 1 Reduce the chance of acute nerve injury exacerbating to destructive injury and improvenerve regeneration Source: DOD grant

Role: Co- Principal Investigator

Direct Funds: $1,600,000

Title: 2 Innovative Sustained Calcitonin Release for Enhanced Peripheral Nerve Regeneration Source: DOD grant

Role: Co- Principal Investigator

PI: Dr Ji-Geng Yan

Direct Funds: $200,000

Title: 4 U.S.-India Science and Technology Endowment Fund along with partner in India Role: Co- Principle Investigator

PI: Dr Umesh Patil

Direct Funds: $450,000

Prior

Peer Review

Title: Dendritic Polymers with Enhanced Amplification and Interior Functionality

Source: Army Research laboratory (ARL) Grant

Role: Team Member/Co-Investigator

Dates: 2004 - Present

Direct Funds: $2,900,000

Title: Combined Targeted Dendrimer Diagnostic-Therapeutic

Source: NIH-SBIR, Small Business Innovation Research program

Role: Team Member/Co-Investigator

Dates: 2006 - Present

Direct Funds: $100,000

Title: Perchlorate Remediation Using New Nanoscale Dendritic Polymer Technology Source: Environmental Research and Development Program (SERDP)

Role: Team Member/Co-Investigator

Dates: 2008 - Present

Direct Funds: $1,100,000

Title: 6 PAMAM Dendrimer Nanotechnology Enabled Formulations of Resveratrol Intended for Anti-oxidant and Anti-cancer Applications

Source: Concordia Intramural Research Grant

Role: Principal Investigator $5,000

Dates: 2012 - Present

Direct Funds: $5,000

Title: Dendrimer nanotechnology-based nasal delivery of a novel drug to treat the negative symptoms of schizophrenia Source: Concordia Intramural Research Grant

Role: Co-Principal Investigator

Dates: 2014 - Present

Direct Funds: $8,000

Title: 7 A Brain Tumor Stem Cell Model for the Evaluation of Novel Metallodrugs to Treat Glioblastoma Source: Thomas A and Lorraine M Rosenberg Award

Role: Co-Principal Investigator

PI: Prof Christopher Chitambar

Dates: 2014 - Present

Direct Funds: $80,000

Title: Dendrimer Nanotechnology based advanced Formulations

Source: National Science Foundation- I Corp subaward

Role: Principal Investigator $2500

Dates: 2015 - Present

Direct Funds: $2,500

Title: A Study to Identify Molecules (similar toRR505) that Targets Dual Specific Phosphatase5 (DUSP5)

Source: NIH-Vascular Interventions/Innovations and Therapeutic Advances (VITA

Role: Co-Investigator

PI: Prof Ramani Ramachandran

Direct Funds: $100,000

Title: Dendrimer-based MRI Contrast Agents

Source: United States Small Business Administration Congressional Earmark Program

Role: Team Member/Co-Investigator $265,000

Direct Funds: $265,000

Title: 5 Development of an experimental approach for studying Ayurvedic concept of tridosha in yeast and rat models Source: MP Council of Science and Technology

Role: Co-Principal Investigator

Direct Funds: $7,000

Non-Peer

Review

Title: To develop sterile compounding lab for Pharmaceutics course sequence

Source: West Foundation Grant

Role: Co- Principal Investigator $50,000

Dates: 2018 - Present

Direct Funds: $50,000

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:

Local

1 Chauhan, A S (2012) Dendrimer Nanotechnology: An Overview Aurora Healthcare, Milwaukee

2 Chauhan, A S (2012) Novel Drug Formulations Drug Development Workshop Clinical &

Translational Science Institute (Plenary Lecture)

3 Chauhan, A S (2018) 'Teaching with Technology' at MCW School of Pharmacy Teaching Certificate

4 Chauhan, A S (2018) 'Slow Release of Calcitonin for Nerve Regeneration' at Plastic Surgery

department, MCW

5 Chauhan, A S (2019) Green anti-aging formulation 4th Annual UWM Innovators Expo

6 Chauhan, A S (2019) Dendrimers for Drug Delivery Lunch and Learn, MCW

Regional

1 Chauhan, A.S (2018) 'Dendrimer technology for cosmetic application' Universal Beauty Products, Inc., Glendale Heights, IL

2 Chauhan, A.S (2019) 'Engineering of "critical nanoscale design parameters" (CNDPs) in PAMAM dendrimer nanoparticles for drug delivery applications' Research publication series, MCW

3 Chauhan, A.S (2019) 'Engineering of "critical nanoscale design parameters" (CNDPs) in PAMAM dendrimer nanoparticles for drug delivery applications' Digital board, MCW

4 Chauhan, A.S (2019) Multi-Step Targeted Teaching In Pharmaceutical Drug Delivery Courses MTSR Retreat, Milwaukee

National

1 Chauhan A.S., Svenson, S., Reyna, L., and Tomalia, D.A (2007) Priostar® Dendrimers as Excipients for Enhanced Drug Solubilization and Controlled Release ENATBIO, Detroit, USA

2 Chauhan, A S., Diwan, P.V., Jain, N.K., and Tomalia D.A (2008) Simple, Terminal Functionalized Poly(amidoamine) (PAMAM) Dendrimers Exhibit In Vivo Activity as Nanoscale Anti-inflammatory Agents Annual American Academy of Nanomedicine Conference, Washington DC (invited

International

1 Chauhan, A S (2011) Dendrimer Nanodevice: Drug Delivery Platform for Advanced Diagnosis and Therapy International conference on imbibing pharmaceutical knowledge to the professionals,

Hyderabad, India (invited talk)

2 Chauhan, A S (2011) Dendrimer Nanotechnology International Workshop on Dendrimer Based Drug Delivery, Lucknow, India (Plenary Lecture)

4 Chauhan, A S (2012) Dendrimer Nanotechnology Pfizer Animal Healthcare, Mumbai, (Invited talk)

5 Chauhan, A S (2012) Nanotechnology: Ayurvedic Perspective 5th world Ayurveda Congress,

Bhopal, (Plenary Lecture)

6 Chauhan, A S (2012) Recent Developments in Nanoscience and Diagnosity Indian Science

Congress, Bhubaneswar, India (Plenary Lecture)

7 Chauhan

8 Chauhan, A.S (2015) Multifunctional dendrimers for enhanced bioavailability International

Dendrimer Symposium (IDS 9), Montreal (Invited talk)

9 Chauhan, A.S (2018) Smart delivery system for active ingredients Current Trends and Advances in Formulations for Cosmetic Applications June 25-26, 2018 at Prof M.L Schroff Memorial Conference Hall, Department of Pharmaceutical Sciences, U.T.D., Sagar (Keynote lecture)

10 Chauhan, A S (2019) Multifunctional Dendrimer Nanotechnology for Drug Delivery EMN

polymers, Hawaii

11 Chauhan, A.S (2019) Dendrimers and its Applications Truba Institute of Pharmacy, Bhopal (Invited Lecture)

12 Singh, M.K., Kuncha, M., Laksham Nayak, V., Sarma, A.V., Jerald Mahesh Kumar, M., Sistla, R., Chauhan, A.S Synthesis and Characterization of Dendrimer Nanotechnology Based Dual-Targeting System for Targeting and Treatment of Glioblastoma American Chemical Society, IICT, Hyderabad, Feb

7, 2019

13 Singh, M.K., Kuncha, M., Laksham Nayak, V., Sarma, A.V., Jerald Mahesh Kumar, M., Sistla, R., Chauhan, A.S Multifunctional hybrid dendrimer with dual-ligands : a next generation dendritic platform for drug delivery IDS 11, Portugal July 2019

3 Chauhan, A S (2011) Dendrimer Nanodevice: A Drug Delivery Platform for Advanced Diagnosis and Therapy 26th MP Young Scientist Congress, Jabalpur, India (Key-Note Lecture)

PEER REVIEWED WORKSHOPS/PRESENTATIONS:

National

1 Svenson, S., Chauhan, A.S., Reyna, L.A., Tomalia, D.A (2006) STARBURST® and Priostar™

Dendrimers for Controlled Drug Delivery Applications 232nd ACS National Meeting, San Francisco,

CA, (invited talk)

2 Svenson, S., Chauhan, A.S., Reyna, L.A., Tomalia, D.A (2006) STARBURST® and Priostar™

Dendrimers for Enhanced Drug Solubilization 232nd ACS National Meeting, San Francisco, CA

3 Svenson, S., Chauhan, A.S., Reyna, L., and Tomalia, D.A (2006) Starburst® and Priostar™

dendrimers for Controlled drug delivery applications Polymer, 47(2), 150-151

4 Svenson, S., Chauhan, A.S., Reyna, L.A., Tomalia, D.A (2006) Dendrimers: A Platform for Custom-Designed Drug Delivery Particles 2006, Orlando, FL (invited talk)

6 Svenson, S., Chauhan, A.S., Zhuravel, M.A (2008) Poly(etherhydroxylamine) PEHAM Dendrimer Nanoparticles for Combination Therapy and Diagnostic 35th Annual Meeting of the Controlled Release Society (CRS)

7 Svenson, S., Chauhan, A.S., Reyna, L.A., Tomalia, D.A (2007) PEHAM Dendrimers for Drug

Delivery Applications Proc 34th Annual Meeting of the Controlled Release Society (CRS), 63

8 Chauhan, A S (2013) Nanomedicines: Addressing the Scientific and Regulatory Gap New York Academy of Sciences, (Discussion Forum)

5 Svenson, S., Chauhan, A.S., Reyna, L.A., Tomalia, D.A (2007) PEHAM Dendrimers for Drug

Delivery Applications 34th Annual Meeting of the Controlled Release Society, Long Beach, CA

International

5 Singh, M.K., Kuncha, M., Laksham Nayak, V., Sarma, A.V., Jerald Mahesh Kumar, M., Sistla, R., Chauhan, A.S Synthesis and Characterization of Dendrimer Nanotechnology Based Dual-Targeting System for Targeting and Treatment of Glioblastoma American Chemical Society, IICT, Hyderabad, Feb

7, 2019

6 Singh, M.K., Kuncha, M., Laksham Nayak, V., Sarma, A.V., Jerald Mahesh Kumar, M., Sistla, R., Chauhan, A.S Hybrid dendrimer- based supramolecular: A next generation dendrimer architecture for drug delivery IDS 11, Portugal July 2019 (POSTER)

4 Svenson, S., Chauhan, A.S., Reyna, L.A (2008) Poly(etherhydroxylamine) PEHAM Dendrimers for Enhanced Drug Solubilization 7th International Symposium on Polymer Therapeutics, Valencia, Spain (invited talk)

1 Khopade, A J., Chauhan, A.S., Nagaich, S., and Jain, N.K (1999) Studies on PAMAM dendrimer - copper (II)-6-Mercaptopurine complex Proceedings of the Controlled Release Society, 26, 769-770

2 Khopade, S A., Khopade, A J., Chauhan, A.S., Tripathi, P., and Jain, N.K (1999) A unimolecular reverse micellar dendrimer for oral delivery of 5-fluorouracil Proceedings of the Controlled Release Society, 26, 953-954

3 Tomalia D.A., Swanson, D.R., Reddy, P.V., Abdelhaddy, H., Chauhan, A.S (2007) 5th international dendrimer symposium Toulouse, France

MEDICAL COLLEGE TEACHING ACTIVITIES:

Graduate Student Education

1 - 2013 Pharmacology graduate program (Drug Discovery class) 3h class

2 - 2014 Models of Disease and Drug Discovery, CTSI 3h class

3 - 2015 Pharmacology graduate program (Drug Discovery class) 3h class

4 - 2017 Pharmacology graduate program (Drug Discovery class) 3h class

5 - 2019 Pharmacology graduate program (Drug Discovery class) 3h class

Course Director: Prof John Imig

Course Director: Prof John Imig

Course Director: Prof John Imig

Course Director: Prof Ramani Ramachandran

Course Director: Prof John Imig

Pharmacy Student Education

1 - Present Pharmaceutical Drug Delivery I: Non-Sterile Products (PHAR 520), 4 credit course (2017) Three parts: Lecture, laboratory and calculation Created and implemented as the course director

2 - Present Pharmaceutical Drug Delivery II: Sterile Products (PHAR 521), 4 credit course (2017) Three parts: Lecture, laboratory and calculation Created and implemented as the course director

3 - Present Pharmaceutical Drug Delivery I: Non-Sterile Products (PHAR 520), 4 credit course (2018) Three parts: Lecture, laboratory and calculation Course director and instructor

4 - Present Pharmaceutical Drug Delivery II: Sterile Products (PHAR 521), 4 credit course (2018) Three parts: Lecture, laboratory and calculation Course director and instructor

5 - Present Independent Study (PHAR 699), 1.5 credit course Dendrimers as Solubility Enhancers chapter in a book 'Pharmaceutical applications of Dendrimers', Elsevier (2018) Becka Anton

6 - Present Independent Study (PHAR 699), 1.5 credit course Therapeutic Dendrimers chapter in a book 'Pharmaceutical applications of Dendrimers', Elsevier (2018) Dominika Krynicka

7 - Present Elective course (PHAR 676) 3 credit course Advanced Drug Delivery Systems: Bench to Bedside (2018)

8 - Present Pharmaceutical Drug Delivery I: Non-Sterile Products (PHAR 520), 4 credit course (2019) Three parts: Lecture, laboratory and calculation Course director and instructor

9 - Present Pharmaceutical Drug Delivery II: Sterile Products (PHAR 521), 4 credit course (2019) Three parts: Lecture, laboratory and calculation Course director and instructor

10 - Present Elective course (PHAR 676) 3 credit course Advanced Drug Delivery Systems: Bench to Bedside (2019)

11 - Present Independent Study (PHAR 699), 1.5 credit course Advanced calcitonin formulation for nerve regeneration (2019: Session 3, 4, 5, 6, 2020: Session 7) Alexender Sperry

12 - Present Independent Study (PHAR 699), 1.5 credit course Advanced gallium - metformin

formulations and dendrimer nanoparticles for GBM and other cancers (2019: Session 3, 4) Roberto Flotte

13 - Present Independent Study (PHAR 699), 1.5 credit course Novel nasal formulation for dryness (2019: Session 5, 6) Princess Graff

14 - Present Independent Study (PHAR 699), 1.5 credit course Dendrimer based resveratrol, CBD topical formulations (2020: Session 3) Tarik Youssef

15 - Present Independent Study (PHAR 699), 1.5 credit course Combo Drug-Gene Delivery via

Dendrimers for Pancreatic Cancer (2020: Session 3) Yen Young

EXTRAMURAL TEACHING:

Graduate Student Education

1 - Present Pharmacy Distant Education Diploma in Pharmacy (1996 -1997), Awadhesh Pratap Singh University, Rewa, India Created syllabus, course books, lab manuals and implemented the program

2 - Present Pharmaceutical engineering (Lecture + laboratory) B Pharm (1999) BR Nahata College of Pharmacy, Mandsaur, India

3 - Present Pharmaceutics III: (PHAR 426), 4 credit course (2012) School of Pharmacy, Concordia University Wisconsin Course Director: Kathie Valdivinos

4 - Present Pharmaceutics II: (PHAR 322), 4 credit course (2012) School of Pharmacy, Concordia University Wisconsin Course Director: Armin Gehardt

5 - Present Pharmaceutics II: (PHAR 322), 4 credit course (2013) School of Pharmacy, Concordia University Wisconsin Course Director: Armin Gehardt

6 - Present Pharmaceutical Biotechnology (PH521) 2 credit (2013) School of Pharmacy, Concordia University Wisconsin Course Director: Christopher Cunningham

7 - Present Pharmaceutics II: (PHAR 322), 4 credit course (2014) School of Pharmacy, Concordia University Wisconsin Course Director: Armin Gehardt

8 - Present Independent Study (PHAR 602), 3 credit course (2014) Evaluation of dendrimer

nanotechnology for Brain delivery of some bioactives Jonas Ricordo Munhoz School of Pharmacy, Concordia University Wisconsin

9 - Present Pharmaceutical Biotechnology (PH523) 2 credit (2014) School of Pharmacy, Concordia University Wisconsin Course Director: Mickle Pickart

10 - Present Pharmaceutics II: (PHAR 322), 4 credit course (2015) School of Pharmacy, Concordia University Wisconsin Course Director: Armin Gehardt

11 - Present Pharmaceutical Biotechnology (PH523) 2 credit (2015) School of Pharmacy, Concordia University Wisconsin Course Director: Prof Mickle Pickart

12 - Present Drug and Consumer Product Design (MPD 534), 3 credit course (2015) Formulation and Drug Delivery Masters in Pharmaceutical/Chemical Development, Concordia University Wisconsin Course Director: Armin Gehardt

13 - Present Pharmaceutics II: (PHAR 322), 4 credit course (2016) School of Pharmacy, Concordia University Wisconsin Course Director: Nancy Stoehr

14 - Present Drug and Consumer Product Design (MPD 599) 3 credit course (2016) Formulation and Drug Delivery Masters in Pharmaceutical/Chemical Development, Concordia University Wisconsin Co-Course Director along with Armin Gerhardt

15 - Present Pharmaceutical Biotechnology (PH523) 2 credit (2016) School of Pharmacy, Concordia University Wisconsin Course Director: Mickle Pickart

16 - Present Drug and Consumer Product Design (MPD 599) 3 credit course (2017) Formulation and Drug Delivery Masters in Pharmaceutical/Chemical Development, Concordia University Wisconsin Course Director: Armin Gerhardt

School of Pharmacy/Graduate Student Education

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:

Undergraduate Students

• Emily Dresen, CUW (2015)

MCW CTSI Start 500 program (2017)

• Enica Saffold

• Alexis Robinson Cooper

Summer Research

Graduate Students

MA Committees

3 Jai Deo Pandey 'Mucoadhesive Microspheres of Antiallergic Agents for Nasal Delivery' Dr APJ Abdul Kalam Technical University Uttar Pradesh, 2018 - Present 2018

MA Students Advised

Co-Supervisor 2019- 2023 (Supervisor Professor Stuart L Graham, Ophthalmology, Department of Clinical Medicine) (Paperwork in progress)

MS Students Advised

1 Hitesh Kulhari, Bundelkhand University, - 2010 India 2010-2012

• Dr Rakesh K Tekade, Assistant Professor, National Institute of Pharmaceutical Education and

Research (NIPER) - Ahmedabad

PharmD Students

• Eric Newenhouse, Pharm D, CUW

• Brennin, O'Brien, Pharm D, CUW

• Hiwot Abebe, Pharm D, CUW

• Mitchelle Groth, Pharm D, CUW

• Jonas, Munoz, Brazil exchange student, CUW

Pharmacy Students

• Dominika Krynicka (2017-2020)

• Ryan Lindstrom (2017-2020)

• Jane Obradovich (2017-2020)

• Anamarie Tomaich (2018-2021)

• Jaclyn Utrie (2018-2021)

• Jacob Voyles (2018-2021)

• Amanda Walter (2018-2021)

• Michael Picciolo (2019-2022)

• Pham Le (2019-2022)

Scholarship Mentee

• Dominika Krynicka (2018)

• Becka Anton (2018)

• Alexendee Sperry (2019-20)

• Roberto Flotte (2019)

• Princess Graff (2019)

• Yen Troung (2020)

• Tarik Youssef ( 2020)

Scholarly Pathway Advisor

• Jane Obrodovich (2018-2019)

• Abdul Jamaleddin (2019-2020)

• Alexander Sperry (2019-2020)

• Anthony Suverdez (2019-2020)

• Glenn Hartle (2019-2020)

• Ly Huynh (2019-2020)

Resident Physician

Dr Andrew Regent-Smith, Resident, Plastic surgery Co-mentoring along with Prof Ji- Geng Yan on the research project 'Innovative Sustained Calcitonin Release for Enhanced Peripheral Nerve Regeneration Academic Mentee

• William Krombholz (2017-2020)

PROGRAMMATIC DEVELOPMENTS:

Research Programs

Established nanotechnology and formulation departments at Dendritic Nanotechnologies Inc (2004-2010, NanoSynthons Inc (2010- 2011) and Concordia University Wisconsin (2011- 2016)

Refereed Journal Publications/Original Papers

1 Reddy, N., Sujatha, P., Chauhan, A.S., Ramkrishna, S., and Diwan, P.V (2003) A simple and sensitive reversed phase HPLC method for determination of celecoxib in rat plasma Indian Journal of

Pharmaceutical sciences, 65(3), 260-263

2 Sridevi, S., Chauhan, A.S., Jain, A., Chalasani, K.B and Diwan,P.V (2003) Evaluation of in vitro and

in vivo bioavailability of complexes of Gliquidone and Hydroxy propyl- cyclodextrin Di- Pharmazie, 58(11), 807-10 PMID: 14664337

3 Chauhan, A S., Sridevi, S., Chalasani, K B., Jain, A., Jain, S.K., Jain N.K., and Diwan P.V (2003) Dendrimer mediated transdermal Delivery: enhanced bioavailability of indomethacin Journal of

controlled release, 90,335-343 PMID: 12880700

4 Chauhan, A S., Jain, N.K., and Diwan, P.V (2004) Solubility Enhancement of Indomethacin using Dendrimer Complex and Bio-disposition Profile of these Complexes in Arthritic Rats J Drug Targeting,

12 (9-10), 575-583 PMID: 15621683

5 Asthana, A., Chauhan, A.S., Diwan, P.V., and Jain, N.K (2005) PAMAM Dendritic Nanostructures for Controlled Site-specific Delivery of Acidic Anti-Inflammatory Active Ingredient AAPS PharmSciTech., 6(3), art no 67

6 Asthana, A., Chauhan, A.S., Diwan, P.V., and Jain, N.K (2005) Poly(amidoamine) (PAMAM)

Dendritic Nanostructures for Controlled Site-specific Delivery of Acidic Anti-Inflammatory Active Ingredient American Association of Pharmaceutical Science (AAPS) PharmSciTech, 6(3), E536-42 PMID: 16354015

7 Ramarao, P., Chalasani, K.B., Chauhan, A S., Jain, A.K., Yandarpu, S K., and Diwan, P.V (2006) Controlled systemic delivery of indomethacin using membrane moderated, cream formulation based transdermal devices Drug delivery, 13(3), 207-13 PMID: 16556573

8 Chauhan, A S., Svenson, S., Reyna, L., Tomalia D.A (2007) Solubility enhancement propensity of PAMAM nanoconstructs Materials Matters- Nanomaterials issue, 2, 24-26 (Invited article)

9 Svenson, S., and Chauhan, A S (2008) Dendrimers for enhanced drug solubilization Nanomedicine, 3(5), 679-702 PMID: 18817470

10 Chauhan, A S., Diwan, P.V., Jain, N.K., and Tomalia D.A (2009) Simple, Terminal Functionalized Poly(amidoamine) (PAMAM) Dendrimers: In Vivo Active Macromolecular Anti-inflammatory Agents Biomacromolecule, (5), 1195-202 PMID: 19348417

11 Chauhan, A S., Jain, N.K., and Diwan, P.V., (2009) Pre-Clinical and Behavioral Toxicity Profile of PAMAM Dendrimer in Mice Proceedings of The Royal Society A doi: 10.1098/rspa.2009.0448

12 Kulhari, H., Pooja, D., Prajapati, S.K., Chauhan, A S (2011) Performance evaluation of PAMAM dendrimer-based Simvastatin formulations International Journal of Pharmaceutics 405(1-2), 203-209 PMID: 21145960

13 Yandrapu, S.K., Kanujia, P., Chalasani, K.B., Mangamoori, L., Kolapalli, R.V Chauhan, A.S (2013) Development and optimization of thiolated dendrimer as a viable mucoadhesive excipient for the

controlled drug delivery: An acyclovir model formulation Nanomedicine: Nanotechnology, Biology and Medicine May;9(4): 514-22 PMID:23117047

14 Kulhari, H., Kulhari, D.P., Prajapati, S.K., Chauhan, A S (2013) Optimization of

carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation Drug Development and

Industrial Pharmacy Nov 18 ( Epub)

15 Kulhari, H., Kulhari, D.P., Singh, M.K., Chauhan, A S (2013) Pharmacokinetic and

Pharmacodynamic Studies of Poly(amidoamine) Dendrimer Based Simvastatin Oral Formulations for the Treatment of Hypercholesterolemia Mol Pharm Jul 1; 10(7):2528-33

16 Tekade, R., Tekade, M., Kumar, M., Chauhan, A.S (2015) Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics Pharmaceutical Research 32(3), 910-928

17 Chauhan, A.S (2015) Dendrimer Nanotechnology for Enhanced Formulation and Controlled

Delivery of Resveratrol : Annals of the New York Academy of Sciences 1348(1):134-40

18 Tekade, R., Maheshwari, R., Sharma,P., Chauhan, A.S (2015) siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector Current Pharmaceutical Design 21(31):4614-36

19 Katare, Y.K., Daya, R.P., Sookram, C., Luckham,R.E., Bhandari, J., Chauhan, A.S *., Mishra, R.K.* (2015) Brain targeting of a water insoluble antipsychotic drug haloperidol via intranasal route using PAMAM dendrimer Mol Pharmaceutics (12 (9),3380-3388 Selected as Editor's choice from American Chemical Society DOI: 0.1021/acs.molpharmaceut.5b00402

20 This article has been recommended in F1000Prime as being of special significance in its field by F1000 Faculty

21 Singh, M.K., Pooja, D.,Kulhari, H., Jain, S.K., Sistla, R., Chauhan, A S (2016) Poly (amidoamine)